Research and Development

The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …

Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …

Carolyn Dodd has taken up a director-level position at healthcare consultancy firm Insight Research Group. Dodd previously spent 12 years …

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …

Michel Dubery has been named as the new managing director of inVentiv Health Communications in Europe. Dubery brings more than …

The number of orphan drug designations in the EU is set to rise to record levels this year, according to …

Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …

Drug discovery and development firm e-Therapeutics hopes to raise £40 million via a new share offer to fund its research …

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …

As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …

Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …

Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …